UFP Technologies [UFPT] vs Conmed [CNMD] Detailed Stock Comparison
UFP Technologies
NASDAQ
Loading...
Conmed
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: UFP Technologies wins in 9 metrics, Conmed wins in 10 metrics, with 0 ties. Conmed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | UFP Technologies | Conmed | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.19 | 15.40 | Conmed |
| Price-to-Book Ratio | 4.35 | 1.68 | Conmed |
| Debt-to-Equity Ratio | 46.98 | 87.93 | UFP Technologies |
| PEG Ratio | 0.97 | -0.53 | Conmed |
| EV/EBITDA | 15.94 | 11.52 | Conmed |
| Profit Margin (TTM) | 11.40% | 8.31% | UFP Technologies |
| Operating Margin (TTM) | 16.45% | 10.62% | UFP Technologies |
| EBITDA Margin (TTM) | 16.45% | 10.62% | UFP Technologies |
| Return on Equity | 19.29% | 11.69% | UFP Technologies |
| Return on Assets (TTM) | 11.53% | 4.03% | UFP Technologies |
| Free Cash Flow (TTM) | $56.94M | $153.88M | Conmed |
| Dividend Yield | N/A | 1.15% | N/A |
| 1-Year Return | -34.79% | -26.24% | Conmed |
| Price-to-Sales Ratio (TTM) | 2.85 | 1.27 | Conmed |
| Enterprise Value | $1.84B | $2.53B | Conmed |
| EV/Revenue Ratio | 3.13 | 1.91 | Conmed |
| Gross Profit Margin (TTM) | 28.80% | 55.01% | Conmed |
| Revenue per Share (TTM) | $77 | $43 | UFP Technologies |
| Earnings per Share (Diluted) | $8.63 | $3.54 | UFP Technologies |
| Beta (Stock Volatility) | 1.14 | 1.17 | UFP Technologies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
UFP Technologies vs Conmed Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| UFP Technologies | 0.08% | -1.98% | -3.21% | -4.21% | -13.75% | -10.83% |
| Conmed | 5.13% | 0.82% | 10.93% | -7.56% | -13.19% | -21.20% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| UFP Technologies | -34.79% | 128.71% | 421.40% | 933.71% | 2,115.54% | 5,602.86% |
| Conmed | -26.24% | -42.25% | -38.83% | -1.30% | 177.71% | 90.76% |
Performance & Financial Health Analysis: UFP Technologies vs Conmed
| Metric | UFPT | CNMD |
|---|---|---|
| Market Information | ||
| Market Cap | $1.68B | $1.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 131,250 | 574,807 |
| 90 Day Avg. Volume | 106,520 | 539,906 |
| Last Close | $219.56 | $55.79 |
| 52 Week Range | $178.26 - $366.41 | $46.00 - $78.19 |
| % from 52W High | -40.08% | -28.65% |
| All-Time High | $366.41 (Sep 23, 2024) | $159.11 (Nov 01, 2021) |
| % from All-Time High | -40.08% | -64.94% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.37% | 0.03% |
| Quarterly Earnings Growth | 0.27% | -0.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.08% |
| Operating Margin (TTM) | 0.16% | 0.11% |
| Return on Equity (TTM) | 0.19% | 0.12% |
| Debt to Equity (MRQ) | 46.98 | 87.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $49.99 | $32.41 |
| Cash per Share (MRQ) | $1.93 | $1.10 |
| Operating Cash Flow (TTM) | $83.37M | $165.21M |
| Levered Free Cash Flow (TTM) | $41.00M | $163.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.15% |
| Last 12-Month Dividend | N/A | $0.60 |
Valuation & Enterprise Metrics Analysis: UFP Technologies vs Conmed
| Metric | UFPT | CNMD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.19 | 15.40 |
| Forward P/E | 25.34 | 11.26 |
| PEG Ratio | 0.97 | -0.53 |
| Price to Sales (TTM) | 2.85 | 1.27 |
| Price to Book (MRQ) | 4.35 | 1.68 |
| Market Capitalization | ||
| Market Capitalization | $1.68B | $1.69B |
| Enterprise Value | $1.84B | $2.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.13 | 1.91 |
| Enterprise to EBITDA | 15.94 | 11.52 |
| Risk & Other Metrics | ||
| Beta | 1.14 | 1.17 |
| Book Value per Share (MRQ) | $49.99 | $32.41 |
Financial Statements Comparison: UFP Technologies vs Conmed
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | UFPT | CNMD |
|---|---|---|
| Revenue/Sales | $151.18M | $321.26M |
| Cost of Goods Sold | $107.63M | $143.50M |
| Gross Profit | $43.54M | $177.75M |
| Research & Development | N/A | $12.95M |
| Operating Income (EBIT) | $24.86M | $15.96M |
| EBITDA | $29.55M | $34.21M |
| Pre-Tax Income | $21.63M | $7.67M |
| Income Tax | $4.45M | $1.64M |
| Net Income (Profit) | $17.18M | $6.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | UFPT | CNMD |
|---|---|---|
| Cash & Equivalents | $14.03M | $35.49M |
| Total Current Assets | $205.89M | $639.00M |
| Total Current Liabilities | $79.87M | $283.15M |
| Long-Term Debt | $181.92M | $891.44M |
| Total Shareholders Equity | $360.67M | $977.64M |
| Retained Earnings | $323.69M | $560.13M |
| Property, Plant & Equipment | $15.26M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | UFPT | CNMD |
|---|---|---|
| Operating Cash Flow | $14.76M | $49.72M |
| Capital Expenditures | $-2.82M | $-3.78M |
| Free Cash Flow | $10.99M | $37.76M |
| Debt Repayment | $-15.64M | $-180.59M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | UFPT | CNMD |
|---|---|---|
| Shares Short | 1.39M | 2.10M |
| Short Ratio | 15.31 | 4.31 |
| Short % of Float | 0.22% | 0.09% |
| Average Daily Volume (10 Day) | 131,250 | 574,807 |
| Average Daily Volume (90 Day) | 106,520 | 539,906 |
| Shares Outstanding | 7.68M | 30.90M |
| Float Shares | 7.42M | 30.68M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 1.19% | 1.15% |
Dividend Analysis & Yield Comparison: UFP Technologies vs Conmed
| Metric | UFPT | CNMD |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.60 |
| Last 12-Month Dividend Yield | N/A | 1.15% |
| 3-Year Avg Annual Dividend | N/A | $0.73 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $2.20 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |